Efg Asset Management (North America) Corp. Moderna, Inc. Transaction History

Efg Asset Management (North America) Corp.

$585 Million
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$101.21 - $166.61 $48,783 - $80,306	482 Added 2.16%	22,809 $2.71 Million
Q1 2024 May 13, 2024	BUY	$85.37 - $115.44 $380,323 - $514,285	4,455 Added 24.93%	22,327 $2.38 Million
Q4 2023 Feb 08, 2024	BUY	$69.51 - $104.43 $195,879 - $294,283	2,818 Added 18.72%	17,872 $1.78 Million
Q3 2023 Nov 02, 2023	SELL	$96.41 - $126.61 $101,134 - $132,813	-1,049 Reduced 6.51%	15,054 $1.55 Million
Q2 2023 Jul 28, 2023	BUY	$118.5 - $160.53 $136,512 - $184,930	1,152 Added 7.71%	16,103 $1.96 Million
Q1 2023 Apr 27, 2023	BUY	$135.66 - $197.02 $2.03 Million - $2.95 Million	14,951 New	14,951 $2.3 Million

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (North America) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (North America) Corp. with notifications on news.

Account